Facilitated PCI associated with worse outcomes than primary PCI

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1527, 2006-01, pp. : 16-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Enoxaparin more than an equal to heparin in PCI

By  

Inpharma, Vol. 1, Iss. 1507, 2005-01 ,pp. : 17-18

Adis International

Access to resources Recommend Favorite

Clinical outcomes are similar for abciximab and eptifibatide in patients who undergo percutaneous coronary intervention (PCI), but abciximab is associated with greater costs

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 493, 2005-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Clinical outcomes are similar for abciximab and eptifibatide in patients who undergo percutaneous coronary intervention (PCI), but abciximab is associated with greater costs

By  

Inpharma, Vol. 1, Iss. 1518, 2005-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Individualised clopidogrel LDs improve PCI outcomes

By  

Inpharma, Vol. 1, Iss. 1632, 2008-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Temporal Trend Might Be Better Than Instant Occurrence of fQRS as a Noninvasive Prognostic Marker in STEMI Patients Undergoing Primary PCI

By Canpolat Uğur   Aras Dursun   Topaloğlu Serkan   Aydoğdu Sinan  

Annals of Noninvasive Electrocardiology, Vol. 20, Iss. 2, 2015-03 ,pp. : 198-199

Blackwell Publishing

Access to resources Recommend Favorite